Jiansen Li, Chen Cao, Xinlu Zhang, Xiaoqun Gong*, Sheng Wang*. A Hypoxia-Responsive Nanomedicine for Cancer Immunotherapy through Ligand Competition-Induced Dual-Prodrug Activation. J. Colloid Interface Sci. 2026, 701, 138774.
点击次数:
上一条:Yangfan Wang, Xiangyu Yang, Miya Zhang, Jiaqi Lei, Shaolong Qi, Kai Yang, Yongcan Li, Wenjie Zhang, Meiqi Cheng, Sheng Wang, Jinqun Gan, Fangfang Cao, Ruibing Wang, Guocan Yu. Supramolecular Microspheres Fabricated from Macrocycle-Incorporated Polymers and Their Biomedical Applications Based on Host-Guest Recognition. Small Methods 2025, 9, e01053.
下一条:Xu Zhang, Zhangzhi Song, Xinyu Zhang, Jianhua Zou*, Guocan Yu*, Xiaoyuan Chen*, Sheng Wang*. Unconventional PROTACs for Targeted Protein Degradation in Cancer Therapy. Angew. Chem. Int. Ed. 2025, 64, e202507702.
